BRPI0906158A2 - composição de liberação modificada compreendendo doxofilina. - Google Patents
composição de liberação modificada compreendendo doxofilina.Info
- Publication number
- BRPI0906158A2 BRPI0906158A2 BRPI0906158A BRPI0906158A BRPI0906158A2 BR PI0906158 A2 BRPI0906158 A2 BR PI0906158A2 BR PI0906158 A BRPI0906158 A BR PI0906158A BR PI0906158 A BRPI0906158 A BR PI0906158A BR PI0906158 A2 BRPI0906158 A2 BR PI0906158A2
- Authority
- BR
- Brazil
- Prior art keywords
- doxophylline
- modified release
- release composition
- composition
- modified
- Prior art date
Links
- HWXIGFIVGWUZAO-UHFFFAOYSA-N doxofylline Chemical compound C1=2C(=O)N(C)C(=O)N(C)C=2N=CN1CC1OCCO1 HWXIGFIVGWUZAO-UHFFFAOYSA-N 0.000 title 1
- 229960004483 doxofylline Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Photolithography (AREA)
- Oscillators With Electromechanical Resonators (AREA)
- Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2008/000554 WO2009112874A1 (en) | 2008-03-10 | 2008-03-10 | Modified release composition comprising doxofylline |
| IBPCT/IB2008/000554 | 2008-03-10 | ||
| PCT/EP2009/052675 WO2009112436A1 (en) | 2008-03-10 | 2009-03-06 | Modified release composition comprising doxofylline |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0906158A2 true BRPI0906158A2 (pt) | 2017-07-18 |
| BRPI0906158B1 BRPI0906158B1 (pt) | 2021-01-05 |
| BRPI0906158B8 BRPI0906158B8 (pt) | 2021-05-25 |
Family
ID=40084194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0906158A BRPI0906158B8 (pt) | 2008-03-10 | 2009-03-06 | composição farmacêutica de liberação modificada compreendendo doxofilina e processo para a preparação de composição |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP2262485A1 (pt) |
| KR (1) | KR101697773B1 (pt) |
| AU (1) | AU2009224801B2 (pt) |
| BR (1) | BRPI0906158B8 (pt) |
| IT (1) | ITMI20080798A1 (pt) |
| MX (2) | MX2008010233A (pt) |
| WO (2) | WO2009112874A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014048511A1 (en) * | 2012-09-26 | 2014-04-03 | Eurodrug Laboratories B.V. | Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations |
| CN103524503B (zh) * | 2013-10-29 | 2014-08-06 | 天津梅花医药有限公司 | 多索茶碱半水化合物 |
| CN110898019A (zh) * | 2019-12-19 | 2020-03-24 | 上海宣泰海门药业有限公司 | 多索茶碱片及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3278491D1 (en) * | 1981-07-15 | 1988-06-23 | Key Pharma | Sustained release theophyline |
| US4772475A (en) * | 1985-03-08 | 1988-09-20 | Yamanouchi Pharmaceutical Co., Ltd. | Controlled-release multiple units pharmaceutical formulation |
| US4837032A (en) * | 1986-02-04 | 1989-06-06 | Farval Ag | Theophylline sustained release tablet |
| US4710384A (en) * | 1986-07-28 | 1987-12-01 | Avner Rotman | Sustained release tablets made from microcapsules |
| US5196203A (en) * | 1989-01-06 | 1993-03-23 | F. H. Faulding & Co. Limited | Theophylline dosage form |
| ES2210321T3 (es) * | 1994-12-19 | 2004-07-01 | Daiichi Pharmaceutical Co., Ltd. | Preparacion granular de liberacion prolongada y procedimiento de produccion. |
| JP2005532321A (ja) * | 2002-05-16 | 2005-10-27 | ファルマシア コーポレーション | 呼吸器の疾患および状態の、選択的ｉＮＯＳ阻害剤とＰＤＥ阻害剤による治療方法、ならびにそのための組成物 |
| US7511159B2 (en) * | 2003-12-25 | 2009-03-31 | Ono Pharmaceutical Co., Ltd. | Azetidine ring compounds and drugs comprising the same |
| US20080025948A1 (en) * | 2004-03-10 | 2008-01-31 | Chih-Ping Liu | Methods of Treatment Using Interferon-Tau |
| WO2006090279A1 (en) * | 2005-02-22 | 2006-08-31 | Pfizer Japan Inc. | Oxyindole derivatives as 5ht4 receptor agonists |
| WO2007120485A2 (en) * | 2006-03-30 | 2007-10-25 | Cinergen, Llc | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor |
| CN100536849C (zh) * | 2006-05-10 | 2009-09-09 | 鲁南制药集团股份有限公司 | 含有茶碱类药物和维生素k的药物组合物 |
| WO2008033351A2 (en) * | 2006-09-11 | 2008-03-20 | Theraquest Biosciences, Inc. | Multimodal abuse resistant and extended release formulations |
| CN101028254B (zh) * | 2007-04-05 | 2010-05-19 | 合肥合源医药科技股份有限公司 | 一种多索茶碱缓释制剂及其制备方法 |
-
2008
- 2008-03-10 MX MX2008010233A patent/MX2008010233A/es active IP Right Grant
- 2008-03-10 WO PCT/IB2008/000554 patent/WO2009112874A1/en active Application Filing
- 2008-03-10 KR KR1020087020018A patent/KR101697773B1/ko active IP Right Grant
- 2008-04-30 IT IT000798A patent/ITMI20080798A1/it unknown
-
2009
- 2009-03-06 WO PCT/EP2009/052675 patent/WO2009112436A1/en active Application Filing
- 2009-03-06 BR BRPI0906158A patent/BRPI0906158B8/pt active IP Right Grant
- 2009-03-06 AU AU2009224801A patent/AU2009224801B2/en active Active
- 2009-03-06 EP EP09721101A patent/EP2262485A1/en not_active Withdrawn
- 2009-03-06 MX MX2010009917A patent/MX2010009917A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0906158B1 (pt) | 2021-01-05 |
| MX2010009917A (es) | 2010-12-21 |
| AU2009224801A1 (en) | 2009-09-17 |
| MX2008010233A (es) | 2009-11-10 |
| WO2009112436A1 (en) | 2009-09-17 |
| ITMI20080798A1 (it) | 2009-09-11 |
| KR20100124860A (ko) | 2010-11-30 |
| BRPI0906158B8 (pt) | 2021-05-25 |
| EP2262485A1 (en) | 2010-12-22 |
| WO2009112874A1 (en) | 2009-09-17 |
| AU2009224801B2 (en) | 2014-06-05 |
| KR101697773B1 (ko) | 2017-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO2021006I1 (no) | Quofenix, delafloksacin | |
| BRPI0906749A2 (pt) | Composição | |
| BRPI1010301A2 (pt) | composição. | |
| BRPI0913808A2 (pt) | composição | |
| BRPI0914869A2 (pt) | composição para lavagem de roupas | |
| BRPI0921327A2 (pt) | Combinação de herbicida-protetor | |
| BRPI0918652A2 (pt) | Composições farmacêuticas e métodos de libração relacionadas. | |
| DE602008002756D1 (de) | Bauzusammensetzung | |
| BRPI0915731A2 (pt) | composição de graxa. | |
| DK2340021T3 (da) | Substituerede pyrrolidin-2-carboxamider | |
| BRPI0915732A2 (pt) | composição de graxa. | |
| IT1392101B1 (it) | Composizione comprendente isoflavoni | |
| BRPI0917231A2 (pt) | composição | |
| BRPI0922480A2 (pt) | compósitos de nanocalcita | |
| BRPI0907925A2 (pt) | Ativadores de glicoquinase. | |
| BRPI0915413A2 (pt) | composição para lavagem de roupas | |
| BRPI0815246A2 (pt) | Composição de catalisador | |
| BRPI0910605A2 (pt) | Composição com sensação de aquecimento | |
| BRPI0907122A2 (pt) | Piridoindóis (1-azinona) substituídos | |
| FR2937049B1 (fr) | Composition de nettoyage. | |
| BRPI0917446A2 (pt) | derivados de acilaminobenzamida. | |
| BRPI0906714A2 (pt) | Derivados de oxazepinopirimidona heteroarilamida substituídos. | |
| BRPI0909422A2 (pt) | conjunto de artigos. | |
| BRPI0917673A2 (pt) | Combinação de herbicida-protetor compreendendo difluorometanossulfonilanilidas substituidas por dimetoxitriazinila | |
| BRPI0922728A2 (pt) | combinação de herbicida-antídoto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/01/2021, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B25G | Requested change of headquarter approved |
Owner name: EURODRUG LABORATORIES B.V. (NL) |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/03/2009 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B25A | Requested transfer of rights approved |
Owner name: PACIFIC HEALTHCARE (THAILAND) CO. LTD (TH) |